Biological evaluation of glucose and deoxyglucose derivatives radiolabeled with [99mTc(CO)3(H2O)3]+ core as potential melanoma imaging agents.
暂无分享,去创建一个
Marcelo Fernández | Pablo Cabral | J. Gambini | J. Chabalgoity | R. Dapueto | W. Porcal | María Moreno | Romina Castelli
[1] Marcelo Fernández,et al. Preparation and primary bioevaluation of 99mTc-labeled-1-thio-β-D-glucose as melanoma targeting agent. , 2011, Current radiopharmaceuticals.
[2] S. Deutscher,et al. Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model. , 2011, Nuclear medicine and biology.
[3] T. Quinn,et al. Synthesis and assessment of 99mTc chelate-conjugated bevacizumab for development of specific radiopharmaceutical , 2010 .
[4] Angélica Figueroa,et al. Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy , 2010, International journal of endocrinology.
[5] Junbo Zhang,et al. Synthesis and biological evaluation of a novel 99mTc(CO)3 complex of ciprofloxacin dithiocarbamate as a potential agent to target infection. , 2010, Bioorganic & medicinal chemistry letters.
[6] T. Storr,et al. Cationic technetium and rhenium complexes with pendant carbohydrates. , 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.
[7] R. J. Alves,et al. A novel D-glucose derivative radiolabeled with technetium-99m: synthesis, biodistribution studies and scintigraphic images in an experimental model of Ehrlich tumor. , 2010, Bioorganic & medicinal chemistry letters.
[8] P. Garg,et al. Design, synthesis, and preliminary in vitro and in vivo evaluation of N-(2-diethylaminoethyl)-4-[18F]fluorobenzamide ([18F]-DAFBA): a novel potential PET probe to image melanoma tumors. , 2009, Bioconjugate chemistry.
[9] M. Mihm,et al. Current concepts of metastasis in melanoma. , 2008, Expert review of dermatology.
[10] R. Saw,et al. Imaging in cutaneous melanoma , 2008, Nuclear medicine communications.
[11] R. Alberto,et al. Technetium and rhenium: coordination chemistry and nuclear medical applications , 2006 .
[12] C. Decristoforo,et al. [99mTc]HYNIC-RGD for imaging integrin αvβ3 expression , 2006 .
[13] Boli Liu,et al. Synthesis and biological evaluation of technetium-99m-labeled deoxyglucose derivatives as imaging agents for tumor. , 2006, Bioorganic & medicinal chemistry letters.
[14] A. Scott,et al. Role of nuclear medicine in the management of cutaneous malignant melanoma. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] S. Oliveria,et al. Sun exposure and risk of melanoma , 2005, Archives of Disease in Childhood.
[16] I. Brink,et al. Factors Influencing [F‐18] 2‐Fluoro‐2‐Deoxy‐d‐Glucose (F‐18 FDG) Uptake in Melanoma Cells: The Role of Proliferation Rate, Viability, Glucose Transporter Expression and Hexokinase Activity , 2005, The Journal of dermatology.
[17] T. Quinn,et al. Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues. , 2003, Bioconjugate chemistry.
[18] David J. Yang,et al. Imaging with 99mTc ECDG targeted at the multifunctional glucose transport system: feasibility study with rodents. , 2003, Radiology.
[19] R. Schibli,et al. Current use and future potential of organometallic radiopharmaceuticals , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[20] C. Lindsley,et al. A general Staudinger protocol for solution-phase parallel synthesis , 2002 .
[21] R. Schibli,et al. Derivatization of glucose and 2-deoxyglucose for transition metal complexation: substitution reactions with organometallic 99mTc and Re precursors and fundamental NMR investigations. , 2001, Chemistry.
[22] R. Wahl. Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.